HPA
MARCH 15, 2022
We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,
HPA
MARCH 15, 2022
We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OurCrowd
JANUARY 13, 2021
The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Read more here.
OurCrowd
APRIL 26, 2022
TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A. The post [Sweetch in PR Newswire] Sweetch Strengthens its Advisory Board with Appointment of Diabetes Care Leader, Dr. Robert A.
AsiaTechDaily
APRIL 30, 2022
Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?
OurCrowd
NOVEMBER 16, 2022
16, 2022 Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Fatima Cody Stanford MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS has joined the company as an advisor. TEL AVIV, Israel, Nov. Read more on PR Newswire here.
OurCrowd
SEPTEMBER 16, 2020
(Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). Read more here.
Expert insights. Personalized for you.
113 
Let's personalize your content